Foundation Medicine (NASDAQ: FMI) reported Q4 EPS of ($1.02), $0.06 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $28.8 million versus the consensus estimate of $29.23 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.